维普期刊资源整合服务平台（V6.5）

151篇 您的检索式：作者名="pedersen TR"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	The Incremental Decrease in Endpoints through Aggressive Lipid Lowering (IDEAL) trial显示文摘	Pedersen TR	2005	American Heart Association Scientific Sessions2005，11，：	1
2	Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis显示文摘	IRossebo AB Pedersen TR Boman K	2008	New England Journal of Medicine2008，359，13：	1
3	Follow-up study of patients randomized in the Seandinavian simvaslalin survival study (4S) of cholesterol lowering 显示文摘	Pedersen TR Wilhelmsen L Faergeman O	2000	Am J Cardiol2000，86，：	1
4	Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease显示文摘	Pyorala K Pedersen TR Kjekshus J ct al	1997	Diabetes Care1997，20，4：	1
5	The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease显示文摘	Kjekshus J Pedersen TR Olsson AG	1997	J Card Fail1997，3，：	1
6	High-dose atorvastatin vs usu- M-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial 显示文摘	Pedersen TR Faergeman O Kastelein ]J	2005	JAMA2005，284，：	1
7	Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin sur vival study(4s)显示文摘	Kjekshus J Pyorala k	1998	Am J Cardiol1998，81，：	1
8	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial in- farction : the IDEAL study : a randomized controlled trial 显示文摘	Pedersen TR Faergeman O Kastelein JJ	2005	JAMA2005，294，19：	1
9	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled trial显示文摘	Pedersen TR Faergeman O Kastelein JJ	2005	JAMA2005，294，：	1
10	High-dose atrovastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled显示文摘	Pedersen TR Faergeman O Kastelein JJ	2005	JAMA2005，294，：	1
11	Intensive lipid lowering with simvastatin and ezetimible in aortic stenosis 显示文摘	Rossebo AB Pedersen TR Bornan K	2008	N Engl J Med2008，359，13：	1
12	Lipopro-tein changes and reduction in the incidence of major coro-nary heart disease events in the Scandinavian simvastatinsurvival study (4S)显示文摘	Pedersen TR Olsson AG Faergeman O	2004	Atheroscler Suppl2004，5，3：	1
13	Highdose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled trial显示文摘	Faerqeman O Kastelein J J	2005	JAMA2005，294，：	1
14	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled trial显示文摘	Pedersen TR Faergeman O Kastelein JJ	2005	JAMA2005，294，19：	1
15	Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the scandinavian simvastatin survival study (4S)显示文摘	Pedersen TR Olsson AG Farergeman O	1998	Circulation1998，97，15：	1
16	HiSh-dose atorvaslatin vs usual-dose simvaslatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled trial显示文摘	Faergeman O Knstelein JJ	2005	JAMA2005，294，：	1
17	Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease:The Scandinavian Simvastatin Survival Study (4S)显示文摘	Pedersen TR Kjekshus J Berg K	2004	Atheroscler Suppl2004，5，3：	1
18	Cholesterol Lowering with Simvastain Improves Prognosis of Diabetic Patients with Coronary Heart Disease显示文摘	Pedersen TR Kjekshus J	1997	Diabetes Care1997，20，：	1
19	Hip joint contact force in the Emu during normal level walking显示文摘	Goetz JE Derrick TR Pedersen DR	2008	J Biomech2008，41，4：	1
20	Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)显示文摘	Pedersen TR Olsson AG Faergeman O	1998	Circulation1998，97，15：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示